You are here:

NICE
NICE Guidance
Conditions and diseases
Musculoskeletal conditions
Spinal conditions

Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy

Highly specialised technologies guidance
Reference number: HST24
Published: 19 April 2023

Guidance
Tools and resources
Information for the public
Evidence
History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance